[PDF][PDF] Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted agents: results …
Journal of clinical oncology, 2009•imdconline.com
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma
Treated With Vascular Endothelial Growt Page 1 Prognostic Factors for Overall Survival in
Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth
Factor–Targeted Agents: Results From a Large, Multicenter Study Daniel YC Heng, Wanling
Xie, Meredith M. Regan, Mark A. Warren, Ali Reza Golshayan, Chakshu Sahi, Bernhard J. Eigl,
J. Dean Ruether, Tina Cheng, Scott North, Peter Venner, Jennifer J. Knox, Kim N. Chi, Christian …
Treated With Vascular Endothelial Growt Page 1 Prognostic Factors for Overall Survival in
Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth
Factor–Targeted Agents: Results From a Large, Multicenter Study Daniel YC Heng, Wanling
Xie, Meredith M. Regan, Mark A. Warren, Ali Reza Golshayan, Chakshu Sahi, Bernhard J. Eigl,
J. Dean Ruether, Tina Cheng, Scott North, Peter Venner, Jennifer J. Knox, Kim N. Chi, Christian …
Purpose
There are no robust data on prognostic factors for overall survival (OS) in patients with metastatic renal cell carcinoma (RCC) treated with vascular endothelial growth factor (VEGF)–targeted therapy.
imdconline.com
